The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Activation of the Somatotropic Axis by Testosterone in Adult Men: Evidence for a Role of Hypothalamic Growth Hormone-Releasing Hormone
Abstract
Testosterone (T) is known to affect the growth hormone (GH) axis. However, the mechanisms underlying the activation of GH secretion by T still remain to be clarified. Available data in animals and humans have shown that withdrawal of somatostatin (SRIH) infusion induces a GH-releasing hormone (GHRH)-mediated rebound release of GH, and there is accumulating evidence that SRIH infusion withdrawal may be a useful test to probe the GHRH function in vivo. With the aim of investigating whether the stimulatory effect of androgens on GH release in man could be accounted for by activation of the hypothalamic GHRH tone, we evaluated the plasma GH response to SRIH withdrawal in 10 patients aged 29.6 ± 2.4 years (mean ± SEM), diagnosed with hypergonadotropic hypogonadism, before and after a 6-month replacement therapy with T enanthate (250 mg every 3 weeks, i.m.), and in 10 healthy men, aged 26.7 ± 2.8 years. To verify whether the modulation of GH secretion by T could also be mediated through changes in SRIH tone and/or pituitary releasable pool, we examined GH secretory responses to combined GHRH and L-arginine (ARG) in the same individuals. Basal plasma concentrations of GH (0.48 ± 0.11 µg/l) and IGF-I (23.79 ± 1.83 nmol/l) were significantly lower in untreated hypogonadal patients than in healthy men, and significantly increased after T replacement therapy (GH 1.13 ± 0.28 µg/l; IGF-I 28.71 ± 1.46 nmol/l). The mean ΔGH peak after SRIH withdrawal recorded in untreated hypogonadal men (2.65 ± 0.86 µg/l) was significantly (p < 0.05) lower than that observed in healthy men (6.53 ± 1.33 µg/l) and significantly increased after T replacement therapy (5.52 ± 1.25 µg/l). The GH responses to GHRH combined with ARG (a functional SRIH antagonist) were not significantly different between healthy men and untreated hypogonadal patients, and were not significantly affected by T treatment. Plasma T and estradiol (E 2) levels significantly correlated with ΔGH peak after SRIH withdrawal in healthy men and in T-treated hypogonadal patients, whereas in untreated patients they did not. No significant correlation was found between GH areas under the curve after GHRH + ARG test and T and E 2 plasma levels in either healthy men or in hypogonadal patients (both before and after T replacement). These findings are consistent with the view that in humans the stimulatory action of T on the GH axis appears to be mediated at the hypothalamic level primarily by promoting GHRH function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated cytokine levels observed in hypogonadal states are associated with truncal obesity, which exacerbates the development of sarcopenia44,45.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [45]
Citations
Cites
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
HO, K. Y., EVANS, W. S., BLIZZARD, R. M., VELDHUIS, J. D., MERRIAM, G. R., SAMOJLIK, E., FURLANETTO, R., ROGOL, A. D., KAISER, D. L., & THORNER, M. O. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-51 · Cited by 921
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
Plotsky, P. M., & Vale, W. (1985) · Science · doi:10.1126/science.2864742 · Cited by 538
Giustina, A. (1998) · Endocrine Reviews · doi:10.1210/er.19.6.717 · Cited by 489
Ghigo, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3323 · Cited by 303
Aimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., & Ghigo, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4837 · Cited by 272
Glutamate: A Major Excitatory Transmitter in Neuroendocrine Regulation
Brann, D. W. (1995) · Neuroendocrinology · doi:10.1159/000126843 · Cited by 257
Veldhuis, J. D., Metzger, D. L., Martha, P. M., Mauras, N., Kerrigan, J. R., Keenan, B., Rogol, A. D., & Pincus, S. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4317 · Cited by 225
KERRIGAN, J. R., & ROGOL, A. D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-281 · Cited by 209
Keenan, B. S. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.996 · Cited by 208
Weissberger, A. J., & Ho, K. K. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501143 · Cited by 185
LINK, K., BLIZZARD, R. M., EVANS, W. S., KAISER, D. L., PARKER, M. W., & ROGOL, A. D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-159 · Cited by 184
Frohman, L. A., Downs, T. R., Clarke, I. J., & Thomas, G. B. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114681 · Cited by 178
Harris, D. A., Vliet, G. V., EGLI, C. A., Grumbach, M. M., Kaplan, S. L., Styne, D. M., & Vainsel, M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-1-152 · Cited by 153
Growth Hormone Secretion Enhanced by Androgen
MARTIN, L. G., CLARK, J. W., & CONNOR, T. B. (1968) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-28-3-425 · Cited by 140
Liu, L. L., Merriam, G. R., & Sherins, R. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-651 · Cited by 132
Veldhuis, J. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3414 · Cited by 132
Ulloa‐Aguirre, A., Blizzard, R. M., García-Rubi, E., Rogol, A. D., Link, K., Christie, C. M., JOHNSON, M. L., & Veldhuis, J. D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-846 · Cited by 124
Giustina, A., Scalvini, T., Tassi, C., Desenzani, P., Poiesi, C., Wehrenberg, W. B., Rogol, A. D., & Veldhuis, J. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3871 · Cited by 99
Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili, A., Mulligan, T., Godschalk, M., Clore, J., Patrie, J., Iranmanesh, A., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8222 · Cited by 98 · cited 1×
“A recent study in healthy elderly men has demonstrated that short-term supraphysiological T supplementation enhances 24-hour basal, pulsatile and nyctohemerally rhythmic GH production and augments the serum insulin-like growth factor I (IGF-I) concentrations [”
BackgroundIranmanesh, A., South, S. A., Liem, A. Y., Clemmons, D. R., Thorner, M. O., WELTMAN, A. L., & Veldhuis, J. D. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390059 · Cited by 90
Valetto, M. R., BELLONE, J., Baffoni, C., Savio, P., Aimaretti, G., Gianotti, L., Arvat, E., Camanni, F., & Ghigo, E. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350568 · Cited by 82
Eakman, G. D., Dallas, J. S., Ponder, S. W., & Keenan, B. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772602 · Cited by 82
Giustina, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1210 · Cited by 74
Hindmarsh, P. C., Brain, C. E., Robinson, I. C. A. F., Matthews, D. R., & Brook, C. G. D. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03548.x · Cited by 72
Uberti, E. C. D., Ambrosio, M. R., Cella, S. G., Margutti, A., Trasforini, G., Rigamonti, A. E., Petrone, E., & Müller, E. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4216 · Cited by 67
Self-citationFryburg, D. A., Weltman, A., Jahn, L. A., Weltman, J. Y., Samojlik, E., Hintz, R. L., & Veldhuis, J. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4379 · Cited by 64
Lumpkin, M. D., Mulroney, S. E., & Haramati, A. (1989) · Endocrinology · doi:10.1210/endo-124-3-1154 · Cited by 55
DiMartino-Nardi, J., WU, R., FISHMAN, K., & Saenger, P. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-902 · Cited by 53
Kerrigan, J. R. (1992) · Endocrine Reviews · doi:10.1210/er.13.2.281 · Cited by 52
Andersen, M., Hansen, T. B., Staving, R. K., Bertelsen, J., Hangaard, J., Petersen, P. H., & Hagen, C. (1996) · University of Southern Denmark Research Portal (University of Southern Denmark) · Cited by 46
Ghigo, E., Arvat, E., Aimaretti, G., Broglio, F., Giordano, R., & Camanni, F. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80027-x · Cited by 45
Sugihara, H., Minami, S., & Wakabayashi, I. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1220583 · Cited by 42
Uberti, E. C. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.2885 · Cited by 41
Magnan, E., Cataldi, M., Guillaume, V., Conte‐Devolx, B., Graziani, N., Figaroli, J. C., Thomas, F., Chihara, K., & Oliver, C. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90610-2 · Cited by 40
Fryburg, D. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3710 · Cited by 36
Miki, N., Ono, M., Miyoshi, H., Tsushima, T., & SHIZUME, K. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90462-1 · Cited by 33
Proposed Mechanisms of Sex-Steroid— Hormone Neuromodulation of the Human GH—IGF-I Axis
Veldhuis, J. D., Evans, W. S., Shah, N., Story, E. S., Bray, M. J., & Anderson, S. M. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1546-2_10 · Cited by 31
Cella, S. G., Luceri, M., Cattaneo, L., Torsello, A., & Müller, E. E. (2008) · Neuroendocrinology · doi:10.1159/000127076 · Cited by 30
Cappa, M., Rigamonti, A. E., Bizzarri, C., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6282 · Cited by 17
Rigamonti, A. E., Cavallera, G., Bonomo, S., Deghenghi, R., Locatelli, V., Cella, S., & Ee, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450635 · Cited by 16
Androgenic Modulation of the Growth Hormone—IGF Axis and Its Impact on Metabolic Outcomes
Fryburg, D. A., WELTMAN, A. L., Jahn, L. A., Weltman, J. Y., Samojlik, E., Hintz, R. L., & Veldhuis, J. D. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1546-2_9 · Cited by 14
Robinson, I. C. A. F., JEFFERY, S., & CLARK, R. G. (1990) · Acta Paediatrica · doi:10.1111/j.1651-2227.1990.tb11640.x · Cited by 12
Rizvi, S. S. R., Weinbauer, G. F., Arslan, M., Partsch, C., & Nieschlag, E. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650337 · Cited by 10
Cappa, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4426 · Cited by 7
Rió, G. D., Carani, C., Velardo, A., Zizzo, G., Massimo, P., Coletta, F., Marrama, P., & Ghigo, E. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349790 · Cited by 6
Research works printed but not linked: 4
- 10.1210/jc.76.6.1407 · doi:10.1210/jc.76.6.1407 · Paper page
- 10.1210/jc.81.3.1217 · DOI
- 10.1210/jc.87.2.825 · doi:10.1210/jc.87.2.825 · Paper page
- 10.1210/jc.83.5.1615 · DOI · Paper page
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis
Gao, Q., Mei, F., Shang, Y., Hu, K., Chen, F., Zhao, L., & Ma, B. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.009 · Cited by 376
Ostan, R., Monti, D., Gueresi, P., Bussolotto, M., Franceschi, C., & Baggio, G. (2016) · Clinical Science · doi:10.1042/cs20160004 · Cited by 260
The Consequences of Altered Somatotropic System on Reproduction1
Chandrashekar, V., Zaczek, D., & Bartke, A. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.027060 · Cited by 175
Metadata
- Authors
- Bondanelli, M., Ambrosio, M. R., Margutti, A., Franceschetti, P., Zatelli, M. C., & degli Uberti, E. C.
- Affiliations
- University of Ferrara (IT)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 77
- Issue
- 6
- Pages
- 380-387
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2040999909
- Cited by
- 58
- References
- 48
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 3 · 2016: 2 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- testosterone, growth hormone secretion, growth hormone-releasing hormone, hypergonadotropic hypogonadism, testosterone replacement therapy, androgens, insulin-like growth factor I, L-arginine, hypothalamic-pituitary axis, adult male, estradiol, somatotropic axis
- MeSH terms
- Adult, Arginine, Estradiol, Heptanoates, Humans, Hypogonadism, Hypothalamus, Insulin-Like Growth Factor I, Male, Pituitary Gland, Radioimmunoassay, Somatostatin, Growth Hormone, Growth Hormone-Releasing Hormone, Testosterone, Immunoradiometric Assay, Case-Control Studies, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.